DOCS.L

Dr. Martens plc
Dr. Martens PLC - Technical change in Permira ownership structure
12th June 2024, 15:35
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2034S
Dr. Martens PLC
12 June 2024
 

 

12 June 2024

Dr. Martens plc

                                                                                                                                                  

Technical change in Permira ownership structure

 

Dr. Martens plc ('the Company') makes this announcement in connection with the TR-1 announcements released today regarding the notification of major holdings by IngreGrsy Limited and IngreLux S.àr.l..

Permira V Fund has undergone a restructure of its holding of shares in Dr. Martens plc, whereby IngreGrsy Limited (a newly incorporated Guernsey company) has replaced IngreLux S.àr.l. (a Luxembourg entity) in the Permira Fund V structure and IngreLux S.àr.l has transferred its 38.46% shareholding in the Company to IngreGrsy Limited.  As a result, IngreGrsy Limited replaced IngreLux S.àr.l. as the Company's largest shareholder with effect from 11 June 2024. The Company, IngreLux S.àr.l. and IngreGrsy Limited also entered into a novation agreement in order for IngreGrsy Limited to replace IngreLux S.à r.l. in the relationship agreement with the Company.  The Permira V Fund ownership structure is otherwise unchanged and remains ultimately controlled by Permira V GP Limited and advised by Permira Advisers LLP.

 

 

Enquiries

Investors and analysts                                                                     

Bethany Barnes, Director of Investor Relations           Bethany.Barnes@drmartens.com   +44 7825 187465

Beth Callum, Investor Relations Manager  Beth.Callum@drmartens.com                          +44 203 995 2644

 

Company Secretariat

Paul Rolling, Assistant Company Secretary   Paul.Rolling@drmartens.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKBBNPBKDBAD]]>
TwitterFacebookLinkedIn